Although exogenous EPO is commonly used in daily clinical practice to treat anemia in patients with chronic kidney failure [5], research has shown that EPO can reduce apoptosis and inflammation, while it promotes angiogenesis, antioxidant activity, and blood oxygen carrying capacity, thus exerting cardioprotective and neuroprotective effects [6, 7]. This evidence concerns the gene EPO and chronic renal failure syndrome.